3-Nitro-N-(4-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide

Catalog No.: 
ACKYNX092
CAS No.: 
2446590-73-2
Molecular Formula: 
C22H16N6O3
Molecular Weight: 
412.41
3-Nitro-N-(4-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$574.00InquiryInquiry
100mg98%$887.00In stockInquiry
250mg98%$2044.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Nitro-N-(4-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide
IUPAC Name3-nitro-N-(4-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide
Molecular FormulaC22H16N6O3
Molecular Weight412.41
SMILESO=C(NC1=CC=C(NC2=NC=CC(C3=CC=CN=C3)=N2)C=C1)C4=CC=CC([N+]([O-])=O)=C4
InChI KeyWMICEFKIAMSLIC-UHFFFAOYSA-N
SynonymBenzamide, 3-nitro-N-[4-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-
CAS No.2446590-73-2

Synthetic Route by SureRoute

1. ACKYNX092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUKYP054 route compound structure diagram
    ACUKYP054150784-74-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKYNX092 route product structure diagram
    ACKYNX0922446590-73-2In Stock
Inquiry

2. ACKYNX092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7In Stock
  4. Then
  5. ACKYNX092 route product structure diagram
    ACKYNX0922446590-73-2In Stock
Inquiry

3. ACKYNX092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGADK973 route compound structure diagram
    ACGADK973329214-79-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKYNX092 route product structure diagram
    ACKYNX0922446590-73-2In Stock
Inquiry

Comments (0)